The Application of Different Sedation Protocols in ICU Patients With Severe Pneumonia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorXiangya Hospital of Central South University

About this trial

This study collected data from 600 patients with severe pneumonia to compare the duration of mechanical ventilation under different sedation regimens in real-world settings. It also evaluated and compared the sedation success rates, hemodynamic changes, and clinical outcomes of patients with severe pneumonia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Respiratory rate ≥ 30 breaths/min; ②Oxygenation index (PaO2/FiO2) ≤ 250;

Involvement of multiple lobes; ④Altered mental status and/or disorientation; ⑤Blood urea nitrogen ≥ 20 mg/dl (7.14 mmol/L); ⑥Systolic blood pressure < 90 mmHg requiring aggressive fluid resuscitation. (2)Patients receiving mechanical ventilation who require sedation treatment. (3)Age ≥ 18 years.

Disqualifiers

Allergic to routine sedative or analgesic medications.

Patients who have not undergone pain and sedation assessment.

Patients transferred to another hospital during treatment.

Patients who abandon treatment and are discharged within less than 72 hours of treatment.

Trial population

From February 1, 2023, to March 30, 2024, diagnosed with severe pneumonia in the Respiratory Intensive Care Unit of Xiangya Hospital, Central South University.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

600 Participants
are grouped into 2 trial groups
Group A: Use cyclopofol group
Group B: Control group

Trial outcomes

Primary outcomes

1

Mechanical ventilation duration

It is defined as the time from intubation (for patients intubated after ICU admission) or ICU admission (for patients already intubated upon ICU admission) to extubation

Time frame
2024.01-2024.12

Secondary outcomes

1

The patient's sedation success rate

The level of sedation was assessed using the Richmond Agitation-Sedation Scale (RASS). Successful sedation was defined by meeting both of the following criteria: a) the proportion of time during the study medication period that the RASS score was between +1 and -2 was ≥ 70.0%; b) no rescue therapy was used.

Time frame
2024.01-2024.12

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.